Loading clinical trials...
Loading clinical trials...
Effect of Intravitreal and Intracameral Injection of Dexamethasone Sodium Phosphate on Mild to Moderate NPDR During Cataract Phacoemulsification
Conditions
Interventions
Dexamethasone sodium phosphate
Locations
1
China
Eye Institute, Affiliated Hospital of Nantong University
Nantong, Jiangsu, China
Start Date
January 31, 2022
Primary Completion Date
April 20, 2025
Completion Date
June 1, 2025
Last Updated
April 30, 2025
NCT05393284
NCT07236645
NCT07230184
NCT06487845
NCT04511715
NCT01853072
Lead Sponsor
Affiliated Hospital of Nantong University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions